During clinical trials, Bristol Myers Squibb's KarXT was said to offer better treatment with fewer side effects. Meanwhile, Pfizer's sickle cell disease treatment Oxbryta was withdrawn from all ...
Chronic stress as a concept has gained significant attention over the last 20 years in the study of laboratory vertebrate model organisms and is now widely studied across many vertebrate species.